Literature DB >> 16009390

Poliovirus replication and spread in primary neuron cultures.

John K Daley1, Lisa A Gechman, Jason Skipworth, Glenn F Rall.   

Abstract

While some neurotropic viruses cause rapid central nervous system (CNS) disease upon entry into the brain parenchyma, other viruses that are cytolytic in the periphery either result in little neuropathology or are associated with a protracted course of CNS disease consistent with persistent infection. One such virus, poliovirus (PV), is an extremely lytic RNA virus that requires the expression of CD155, the poliovirus receptor (PVR), for infection. To compare the kinetics of PV infection in neuronal and non-neuronal cell types, primary hippocampal neurons and fibroblasts were isolated from CD155+ transgenic embryos and infected with the Mahoney and Sabin strains of PV. Despite similar levels of infection in these ex vivo cultures, PV-infected neurons produced 100-fold fewer infectious particles as compared to fibroblasts throughout infection, and death of PV-infected neurons was delayed approximately 48 h. Spread in neurons occurred primarily by trans-synaptic transmission and was CD155-dependent. Together, these results demonstrate that the magnitude and speed with which PV replication, spread, and subsequent cell death occur in neurons is decreased as compared to non-neuronal cells, implicating cell-specific effects on replication that may then influence viral pathogenesis.

Entities:  

Mesh:

Year:  2005        PMID: 16009390     DOI: 10.1016/j.virol.2005.05.032

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

1.  Acid sphingomyelinase deficiency increases susceptibility to fatal alphavirus encephalomyelitis.

Authors:  Ching G Ng; Diane E Griffin
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

2.  Contemporary Circulating Enterovirus D68 Strains Infect and Undergo Retrograde Axonal Transport in Spinal Motor Neurons Independent of Sialic Acid.

Authors:  Alison M Hixon; Penny Clarke; Kenneth L Tyler
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

3.  Mechanisms controlling virulence thresholds of mixed viral populations.

Authors:  Karen Z Lancaster; Julie K Pfeiffer
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

Review 4.  Targeting PVR (CD155) and its receptors in anti-tumor therapy.

Authors:  Paola Kučan Brlić; Tihana Lenac Roviš; Guy Cinamon; Pini Tsukerman; Ofer Mandelboim; Stipan Jonjić
Journal:  Cell Mol Immunol       Date:  2018-10-01       Impact factor: 11.530

Review 5.  Understanding the Role of Antiviral Cytokines and Chemokines on Neural Stem/Progenitor Cell Activity and Survival.

Authors:  Manisha N Chandwani; Patrick S Creisher; Lauren A O'Donnell
Journal:  Viral Immunol       Date:  2018-10-10       Impact factor: 2.257

6.  A phylogenetically conserved RNA structure in the poliovirus open reading frame inhibits the antiviral endoribonuclease RNase L.

Authors:  Jian-Qiu Han; Hannah L Townsend; Babal Kant Jha; Jayashree M Paranjape; Robert H Silverman; David J Barton
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

Review 7.  Inadequately treated wastewater as a source of human enteric viruses in the environment.

Authors:  Anthony I Okoh; Thulani Sibanda; Siyabulela S Gusha
Journal:  Int J Environ Res Public Health       Date:  2010-06-14       Impact factor: 3.390

Review 8.  Molecular Pathogenicity of Enteroviruses Causing Neurological Disease.

Authors:  Anna Majer; Alan McGreevy; Timothy F Booth
Journal:  Front Microbiol       Date:  2020-04-09       Impact factor: 5.640

Review 9.  Neurotropic Enterovirus Infections in the Central Nervous System.

Authors:  Hsing-I Huang; Shin-Ru Shih
Journal:  Viruses       Date:  2015-11-24       Impact factor: 5.048

10.  Flow cytometric detection and serotyping of enterovirus for the clinical laboratory.

Authors:  Rosemary C She; Sergey N Preobrazhensky; Edward W Taggart; Cathy A Petti; David W Bahler
Journal:  J Virol Methods       Date:  2009-09-04       Impact factor: 2.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.